| DC Field | Value | Language |
|---|
| dc.contributor.author | Voronov, A. V. | - |
| dc.contributor.author | Gapoyan, L. M. | - |
| dc.contributor.author | Chertkov, K. D. | - |
| dc.contributor.author | Zhilyakova, E. T. | - |
| dc.contributor.author | Veretennikov, E. A. | - |
| dc.date.accessioned | 2026-03-24T14:08:27Z | - |
| dc.date.available | 2026-03-24T14:08:27Z | - |
| dc.date.issued | 2025 | - |
| dc.identifier.citation | Effect of crystalline and amorphous forms of N-butyl-1,5-dideoxy-1,5-imino-d-glucitol on technological processes in production of the finished dosage form / A.V. Voronov, L.M. Gapoyan, K.D. Chertkov [et al.] // Pharmaceutical Chemistry Journal. - 2025. - Vol.58, №11.-P. 1742-1746. - Doi: 10.1007/s11094-025-03333-z. - Refer.: p. 1746. | ru |
| dc.identifier.uri | http://dspace.bsuedu.ru/handle/123456789/66395 | - |
| dc.description.abstract | The bioequivalence of finished dosage forms obtained from pharmaceutical compositions containing amorphous and crystalline forms of N-butyl-1,5-dideoxy-1,5-imino-D-glucitol as the active ingredient was demonstrated | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | amorphous form | ru |
| dc.subject | crystalline form | ru |
| dc.subject | electrification | ru |
| dc.subject | static electricity | ru |
| dc.subject | chemical substances | ru |
| dc.title | Effect of crystalline and amorphous forms of N-butyl-1,5-dideoxy-1,5-imino-d-glucitol on technological processes in production of the finished dosage form | ru |
| dc.type | Article | ru |
| Appears in Collections: | Статьи из периодических изданий и сборников (на иностранных языках) = Articles from periodicals and collections (in foreign languages)
|
